XML 18 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating Activities    
Net income including the noncontrolling interests in subsidiaries $ 48,774 $ 36,418
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities    
Amortization of deferred sales commissions 2,904 4,018
Depreciation and other amortization 2,351 2,507
Share-based compensation expense 7,236 6,901
Loss on disposal of assets 1,174 551
Provision for deferred income taxes 9,270 8,415
Adoption of new accounting pronouncement (2,653) 0
Net purchases of trading securities (2,831) (3,950)
Deferred sales commissions paid (3,012) (4,448)
Contingent deferred sales charges received 578 549
Other changes in assets and liabilities:    
Increase in receivables, net (7,454) (646)
(Increase) decrease in prepaid expenses and other assets (1,750) 1,574
Decrease in accounts payable and accrued expenses (41,722) (46,854)
Increase in other liabilities 12,780 9,628
Net cash provided by operating activities 25,645 14,663
Investing Activities    
Purchases of securities available for sale (823) (943)
Proceeds from redemptions of securities available for sale 50 0
Cash paid for property and equipment (3,257) (1,008)
Net cash used by investing activities (4,030) (1,951)
Financing Activities    
Dividends paid (25,990) (26,202)
Purchases of treasury stock (13,728) (10,276)
Distributions to noncontrolling interest in subsidiaries (6,345) (815)
Contributions from noncontrolling interest in subsidiaries 5,431 5,785
Proceeds from shareholders for share-based compensation 0 81
Excess tax benefits from share-based compensation 596 1,656
Cash paid for business acquisitions (70) 0
Payments on debt (6,375) (6,375)
Net cash used by financing activities (46,481) (36,146)
Net decrease in cash and cash equivalents (24,866) (23,434)
Cash and cash equivalents, beginning of period 172,628 115,267
Cash and cash equivalents, end of period $ 147,762 $ 91,833